Core Scientific Quarterly Balance Sheet
NASDAQ: CORZFinanceFinance: Consumer ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Core Scientific financial position
As of Jun 30, 2026, Core Scientific reported total assets of $5.26 billion, up 184.1% from a year earlier against total liabilities of $7.68 billion. Shareholders' equity was negative at -$2.42 billion, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $1.77 billion in cash and equivalents against $4.30 billion of debt, a net debt position of $2.53 billion.
The current ratio (current assets divided by current liabilities) was 0.89, meaning short-term obligations exceed short-term assets.
Summary generated from market data by MetaCap's automated system. Methodology
Core Scientific balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.77B | 1.01B | 311.38M | 453.44M | 581.35M | 697.94M | 836.20M | 253.02M | 96.12M | 98.13M | 50.41M | 42.15M |
| Receivables | — | — | — | — | — | 1.02M | 1.02M | 6.24M | 4.68M | 1.11M | 1.00M | — |
| Total Current Assets | 2.44B | 1.45B | 895.54M | 1.06B | 1.00B | 833.18M | 903.96M | 277.86M | 117.86M | 143.32M | 97.02M | 134.72M |
| Property, Plant & Equipment | 1.77B | 1.34B | 1.29B | 954.13M | 701.29M | 522.98M | 433.47M | 453.17M | 452.73M | 575.97M | 585.43M | 547.30M |
| Goodwill | — | — | — | — | — | — | — | — | — | — | 0 | — |
| Intangible Assets | 228.63M | — | 1.08M | — | — | — | — | — | — | 2.14M | 2.25M | 2.45M |
| Total Assets | 5.26B | 3.07B | 2.35B | 2.17B | 1.85B | 1.50B | 1.48B | 824.59M | 664.20M | 813.97M | 712.16M | 705.46M |
| Accounts Payable | 112.37M | 218.86M | 126.11M | 212.18M | 215.06M | 6.33M | 19.27M | 6.50M | 8.49M | 16.16M | 154.75M | 45.53M |
| Short-Term Debt | — | 993.94M | 0 | — | — | — | — | — | — | — | — | — |
| Total Current Liabilities | 2.74B | 2.66B | 781.40M | 669.86M | 562.72M | 195.51M | 134.56M | 76.51M | 74.82M | 138.15M | 488.42M | 312.66M |
| Long-Term Debt | 4.30B | 1.06B | 1.06B | 1.06B | 1.06B | 1.07B | 1.07B | 474.60M | 526.76M | 556.57M | 684.08M | 679.56M |
| Total Liabilities | 7.68B | 4.38B | 3.31B | 3.42B | 3.04B | 1.81B | 2.42B | 1.65B | 1.85B | 1.13B | 1.31B | 1.12B |
| Shareholders' Equity | -2.42B | -1.31B | -962.74M | -1.25B | -1.19B | -308.82M | -943.05M | -826.66M | -1.18B | -318.51M | -596.94M | -418.73M |
| Retained Earnings | -5.65B | -4.49B | -4.15B | -4.36B | -4.22B | -3.28B | -3.86B | -3.57B | -3.11B | -2.21B | -2.42B | -2.22B |
| Total Debt | 4.30B | 2.06B | 1.06B | 1.06B | 1.06B | 1.07B | 1.07B | 474.60M | 526.76M | 556.57M | 684.08M | 679.56M |
| Net Cash (Debt) | -2.53B | -1.05B | -748.95M | -605.56M | -476.35M | -373.90M | -237.79M | -221.58M | -430.63M | -458.45M | -633.67M | -637.41M |
| Shares Outstanding | 319.59M | 316.95M | 314.23M | 308.38M | 303.15M | 299.09M | 292.61M | 279.82M | 187.89M | 182.24M | 386.88M | 385.87M |
This table shows 12 quarterly periods of Core Scientific's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow CORZ's reporting calendar. What is a balance sheet?